Lifeline Drugs & Pharma has informed that the meeting of Board of Directors of the Company will be held on November 10, 2016, to consider Un-Audited Financial Results (Provisional) for the 2nd quarter ended on September 30, 2016 (Q-II) for the financial year ended on March 31, 2017. Further, in terms of Company’s Code of Conduct to regulate, monitor and report trading by Insiders, as formulated and adopted under the SEBI (Prohibition of Insider Trading) Regulations, 2015 the trading window for dealing in shares of the Company will remain close for designated persons, insiders and their immediate relatives from November 03, 2016 to November 15, 2016.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
ICICI Securities | 730.50 |
Angel One | 2819.00 |
Motilal Oswal Fin | 2600.65 |
Share India Sec. | 1686.00 |
SMC Global Sec. | 147.70 |
View more.. |